Hu-Lieskovan Siwen

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

J. Wargo, P. Sharma, A. Ribas, 2017, Cell.

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.

T. Graeber, T. Schumacher, B. Comin-Anduix, 2016, The New England journal of medicine.

Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?

A. Ribas, S. Hu-Lieskovan, L. Robert, 2016, Seminars in immunology.

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAFV600E melanoma

T. Graeber, B. Comin-Anduix, A. Ribas, 2015, Science Translational Medicine.

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Ying S. Ting, R. Govindan, Michael S. Rooney, 2020, Cell.

Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?

E. V. Van Allen, C. Drake, J. Allison, 2019, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Inflammation and Lung Cancer: Addressing Inflammation with Immunotherapy

J. Lee, S. Hu-Lieskovan, S. Dubinett, 2015 .

Combining targeted therapy with immunotherapy in BRAF-mutant melanoma: promise and challenges.

A. Ribas, S. Hu-Lieskovan, L. Robert, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial

J. Sosman, A. Ribas, P. Scumpia, 2023, Nature Medicine.

A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy.

M. Kahn, H. Lenz, W. Zhang, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.

T. Triche, Jingsong Zhang, S. Hu-Lieskovan, 2005, Cancer research.